よむ、つかう、まなぶ。
05資料2-1森野委員提出資料（RSウイルス母子免疫ワクチンと抗体製剤ファクトシート） (44 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_64997.html |
| 出典情報 | 厚生科学審議会 予防接種・ワクチン分科会 予防接種基本方針部会 ワクチン評価に関する小委員会（第32回 10／22）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
16.
Zhao S, Shang Y, Yin Y, et al. Ziresovir in Hospitalized Infants with Respiratory Syncytial Virus
Infection. N Engl J Med 2024; 391(12): 1096-107.
17.
Lei C, Wan C. Retrospective analysis of clinical characteristics and treatment differences
between severe and non-severe neonatal types of pneumonia with RSV infection. Medicine (Baltimore)
2025; 104(2): e41177.
18.
Fernandes RM, Bialy LM, Vandermeer B, et al. Glucocorticoids for acute viral bronchiolitis in
infants and young children. Cochrane Database of Systematic Reviews 2013; (6).
19.
Mazur NI, Caballero MT, Nunes MC. Severe respiratory syncytial virus infection in children:
burden, management, and emerging therapies. Lancet 2024; 404(10458): 1143-56.
20.
Farley R, Spurling GKP, Eriksson L, Del Mar CB. Antibiotics for bronchiolitis in children under
two years of age. Cochrane Database of Systematic Reviews 2014; (10).
21.
Ferolla FM, Soffe J, Mistchenko A, Contrini MM, López EL. Clinical and epidemiological impact
of respiratory syncytial virus and identification of risk factors for severe disease in children hospitalized
due to acute respiratory tract infection. Arch Argent Pediatr 2019; 117(4): 216-23.
22.
Huang L, Ye C, Zhou R, Ji Z. Diagnostic value of routine blood tests in differentiating between
SARS-CoV-2, influenza A, and RSV infections in hospitalized children: a retrospective study. BMC
Pediatr 2024; 24(1): 328.
23.
Rose EB, Washington EJ, Wang L, et al. Multiple Respiratory Syncytial Virus Introductions
Into a Neonatal Intensive Care Unit. J Pediatric Infect Dis Soc 2021; 10(2): 118-24.
24.
Welliver R. Bronchiolitis and Infectious Asthma. In: Cherry JD, Harrison GJ, Kaplan SL,
Steinbach WJ, Hotez PJ, eds. Feigin & Cherry's Textbook of Pediatric Infectious Diseases. eighth ed.
Philadelphia: ELSEVIER; 2019: 1780-97.
25.
Collins PL, Fearns R, Graham BS. Respiratory syncytial virus: virology, reverse genetics, and
pathogenesis of disease. Curr Top Microbiol Immunol 2013; 372: 3-38.
26.
Battles MB, McLellan JS. Respiratory syncytial virus entry and how to block it. Nat Rev
Microbiol 2019; 17(4): 233-45.
27.
Miller RJ, Mousa JJ. Structural basis for respiratory syncytial virus and human
metapneumovirus neutralization. Curr Opin Virol 2023; 61: 101337.
28.
McLellan JS. Neutralizing epitopes on the respiratory syncytial virus fusion glycoprotein. Curr
Opin Virol 2015; 11: 70-5.
29.
Fedechkin SO, George NL, Wolff JT, Kauvar LM, DuBois RM. Structures of respiratory
syncytial virus G antigen bound to broadly neutralizing antibodies. Sci Immunol 2018; 3(21).
30.
van Dijk LLA, Rijsbergen LC, Rubio BT, et al. Virus neutralization assays for human
respiratory syncytial virus using airway organoids. Cell Mol Life Sci 2024; 81(1): 267.
31.
Goya S, Ruis C, Neher RA, et al. Standardized Phylogenetic Classification of Human
Respiratory Syncytial Virus below the Subgroup Level. Emerg Infect Dis 2024; 30(8): 1631-41.
32.
白戸憲也, 高山郁代, 冨田有里子, et al. 病原体検出マニュアル ヒトオルソニューモウイルス (RS
ウイルス). 国立感染症研究所. 2023. https://id-info.jihs.go.jp/relevant/manual/010/RSVirus20230807.pdf
44
Zhao S, Shang Y, Yin Y, et al. Ziresovir in Hospitalized Infants with Respiratory Syncytial Virus
Infection. N Engl J Med 2024; 391(12): 1096-107.
17.
Lei C, Wan C. Retrospective analysis of clinical characteristics and treatment differences
between severe and non-severe neonatal types of pneumonia with RSV infection. Medicine (Baltimore)
2025; 104(2): e41177.
18.
Fernandes RM, Bialy LM, Vandermeer B, et al. Glucocorticoids for acute viral bronchiolitis in
infants and young children. Cochrane Database of Systematic Reviews 2013; (6).
19.
Mazur NI, Caballero MT, Nunes MC. Severe respiratory syncytial virus infection in children:
burden, management, and emerging therapies. Lancet 2024; 404(10458): 1143-56.
20.
Farley R, Spurling GKP, Eriksson L, Del Mar CB. Antibiotics for bronchiolitis in children under
two years of age. Cochrane Database of Systematic Reviews 2014; (10).
21.
Ferolla FM, Soffe J, Mistchenko A, Contrini MM, López EL. Clinical and epidemiological impact
of respiratory syncytial virus and identification of risk factors for severe disease in children hospitalized
due to acute respiratory tract infection. Arch Argent Pediatr 2019; 117(4): 216-23.
22.
Huang L, Ye C, Zhou R, Ji Z. Diagnostic value of routine blood tests in differentiating between
SARS-CoV-2, influenza A, and RSV infections in hospitalized children: a retrospective study. BMC
Pediatr 2024; 24(1): 328.
23.
Rose EB, Washington EJ, Wang L, et al. Multiple Respiratory Syncytial Virus Introductions
Into a Neonatal Intensive Care Unit. J Pediatric Infect Dis Soc 2021; 10(2): 118-24.
24.
Welliver R. Bronchiolitis and Infectious Asthma. In: Cherry JD, Harrison GJ, Kaplan SL,
Steinbach WJ, Hotez PJ, eds. Feigin & Cherry's Textbook of Pediatric Infectious Diseases. eighth ed.
Philadelphia: ELSEVIER; 2019: 1780-97.
25.
Collins PL, Fearns R, Graham BS. Respiratory syncytial virus: virology, reverse genetics, and
pathogenesis of disease. Curr Top Microbiol Immunol 2013; 372: 3-38.
26.
Battles MB, McLellan JS. Respiratory syncytial virus entry and how to block it. Nat Rev
Microbiol 2019; 17(4): 233-45.
27.
Miller RJ, Mousa JJ. Structural basis for respiratory syncytial virus and human
metapneumovirus neutralization. Curr Opin Virol 2023; 61: 101337.
28.
McLellan JS. Neutralizing epitopes on the respiratory syncytial virus fusion glycoprotein. Curr
Opin Virol 2015; 11: 70-5.
29.
Fedechkin SO, George NL, Wolff JT, Kauvar LM, DuBois RM. Structures of respiratory
syncytial virus G antigen bound to broadly neutralizing antibodies. Sci Immunol 2018; 3(21).
30.
van Dijk LLA, Rijsbergen LC, Rubio BT, et al. Virus neutralization assays for human
respiratory syncytial virus using airway organoids. Cell Mol Life Sci 2024; 81(1): 267.
31.
Goya S, Ruis C, Neher RA, et al. Standardized Phylogenetic Classification of Human
Respiratory Syncytial Virus below the Subgroup Level. Emerg Infect Dis 2024; 30(8): 1631-41.
32.
白戸憲也, 高山郁代, 冨田有里子, et al. 病原体検出マニュアル ヒトオルソニューモウイルス (RS
ウイルス). 国立感染症研究所. 2023. https://id-info.jihs.go.jp/relevant/manual/010/RSVirus20230807.pdf
44